How many stocks are there of Masimo?
The current number of stocks of Masimo is 54.1 M undefined.
Masimo Stocks 2024
Masimo Stocks
54.1 M
Ticker
MASI
ISIN
US5747951003
WKN
578074
In 2024, Masimo had 54.1 M outstanding stocks, a 0% change from the 54.1 M stocks in the previous year.
The Masimo Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2029e | 54.1 |
| 2028e | 54.1 |
| 2027e | 54.1 |
| 2026e | 54.1 |
| 2025e | 54.1 |
| 2024e | 54.1 |
| 2023 | 54.1 |
| 2022 | 55.2 |
| 2021 | 57.7 |
| 2020 | 58 |
| 2019 | 57.1 |
| 2018 | 56 |
| 2017 | 55.9 |
| 2016 | 53.2 |
| 2015 | 53.7 |
| 2014 | 55.6 |
| 2013 | 57.5 |
| 2012 | 58.4 |
| 2011 | 60.8 |
| 2010 | 60.6 |
| 2009 | 60.2 |
| 2008 | 60.2 |
| 2007 | 59.8 |
| 2006 | 52.8 |
| 2005 | 52.8 |
| 2004 | 52.8 |
Masimo shares outstanding US5747951003 · 578074
The number of shares was Masimo in 2023 — This indicates how many shares 54.1 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Masimo earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Masimo's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Masimo’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Masimo's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 52.8 M Aktien |
| 2005 | 52.8 M Aktien |
| 2006 | 52.8 M Aktien |
| 2007 | 59.8 M Aktien |
| 2008 | 60.2 M Aktien |
| 2009 | 60.2 M Aktien |
| 2010 | 60.6 M Aktien |
| 2011 | 60.8 M Aktien |
| 2012 | 58.4 M Aktien |
| 2013 | 57.5 M Aktien |
| 2014 | 55.6 M Aktien |
| 2015 | 53.7 M Aktien |
| 2016 | 53.2 M Aktien |
| 2017 | 55.9 M Aktien |
| 2018 | 56 M Aktien |
| 2019 | 57.1 M Aktien |
| 2020 | 58 M Aktien |
| 2021 | 57.7 M Aktien |
| 2022 | 55.2 M Aktien |
| 2023 | 54.1 M Aktien |
| 2024e | 54.1 M Aktien |
| 2025e | 54.1 M Aktien |
| 2026e | 54.1 M Aktien |
| 2027e | 54.1 M Aktien |
| 2028e | 54.1 M Aktien |
| 2029e | 54.1 M Aktien |
Masimo Aktienanalyse
What does Masimo do?
Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Masimo's Shares Outstanding
Masimo's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Masimo’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Masimo’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Masimo’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Masimo stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Masimo are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Masimo evolved in recent years?
The number of shares of Masimo has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Masimo as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Masimo?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Masimo pay?
Over the past 12 months, Masimo paid a dividend of 1 USD . This corresponds to a dividend yield of about 0.9 %. For the coming 12 months, Masimo is expected to pay a dividend of 0 USD.
What is the dividend yield of Masimo?
The current dividend yield of Masimo is 0.9 %.
When does Masimo pay dividends?
Masimo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Masimo?
Masimo paid dividends every year for the past 0 years.
What is the dividend of Masimo?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Masimo located?
Masimo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Masimo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Masimo from 12/11/2012 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 11/23/2012.
When did Masimo pay the last dividend?
The last dividend was paid out on 12/11/2012.
What was the dividend of Masimo in the year 2023?
In the year 2023, Masimo distributed 0 USD as dividends.
In which currency does Masimo pay out the dividend?
The dividends of Masimo are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Masimo stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Masimo
Our stock analysis for Masimo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Masimo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
